Cargando…
New developments in transcatheter therapy of mitral valve disease
Mitral valve regurgitation (MR) belongs to one of the most common acquired valve diseases in western countries with increasing prevalence in older age. For patients with high perioperative risk and older age prohibitive for valve surgery, the development of transcatheter mitral valve therapies offer...
Autores principales: | Walther, Claudia, Fichtlscherer, Stephan, Holubec, Tomas, Vasa-Nicotera, Mariuca, Arsalan, Mani, Walther, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212154/ https://www.ncbi.nlm.nih.gov/pubmed/32395315 http://dx.doi.org/10.21037/jtd.2019.12.137 |
Ejemplares similares
-
Current issues in transcatheter aortic valve replacement
por: Mas-Peiro, Silvia, et al.
Publicado: (2020) -
Nutritional risk index is a better predictor of early mortality than conventional nutritional markers after transcatheter aortic valve replacement: A prospective cohort study
por: Mas-Peiro, Silvia, et al.
Publicado: (2021) -
Cerebral oxygen saturation as outcome predictor after transfemoral transcatheter aortic valve implantation
por: Seppelt, Philipp C., et al.
Publicado: (2022) -
Mechanical injury of the anterior mitral leaflet late after transcatheter aortic valve implantation
por: Miura, Mizuki, et al.
Publicado: (2019) -
Protamine induced right ventricular dysfunction and systemic hypotension during transcatheter aortic valve replacement
por: Hamid, Arsalan, et al.
Publicado: (2021)